Trial Profile
Mizoribine Versus Mycophenolate Mofetil after living donor kidney transplantation for Gastrointestinal Symptoms: a retrospective study in China
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jan 2017
Price :
$35
*
At a glance
- Drugs Mizoribine (Primary) ; Mycophenolate mofetil (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Adverse reactions
- 01 Jan 2017 Results published in the Transplantation Proceedings
- 27 Apr 2016 New trial record